Hyderabad's Hetero Labs partners with European giant Gedeon Richter. They will jointly develop and sell Semaglutide Injection, the generic ...

India may be adding more trade partners, but its latest FTA report card comes with several red marks. A new study by the Global Trade Resea...

If the US-Iran ceasefire holds, the markets may see some recovery. The movement of crude oil prices and its impact on the markets supports ...

An Indian woman's viral video reveals how common services in India are costly or unavailable in the UK. She points out differences in deliv...

As visa hurdles rise in traditional study destinations, Indian students are increasingly turning to France. While easier visas and English-...

Pfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...

As nothing can be ruled out on the street, be prepared for anything. Now, what is the probability that the bears will be chased away from t...

India’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...

A new India-EU free trade agreement promises to boost Indian pharmaceutical exports. Lower tariffs will make Indian medicines more competit...

The Indian government is in the final stages of introducing a national policy to promote research, development, and innovation in the pharm...

Indoco Remedies on Friday said it has received the EU GMP certification for its manufacturing site located in Himachal Pradesh. The company...

“We want to bring the drugs which are not available in India. The biggest factor is affordability. If you bring a medicine which is not aff...

The Indian Pharmaceutical Alliance (IPA) and various pharma industry associations in India and other key stakeholders in the pharmaceutical...

The statement further said that the alliance is working closely with the International generic and biosimilar medicines association, the WH...

The move to produce medicine formulations that incorporate hemp lend a fresh reputation to the otherwise controversial cannabis

According to a recently issued statement, the products will be made available in the hospital market in March this year in the area of onco...

Cipla has launched multiple respiratory products in Europe this year, and launch of some key inhalers is expected in 2015.